Clinical Trials Browser

Withdrawn × Interventional × Immunotherapy, Adoptive × Clear all

NCT03768310 2022-07-21

CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02575261 2020-07-16

CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients

Phase 1/2 Withdrawn

Glioma

NCT02723942 2020-07-16

CAR-T Cell Immunotherapy for HCC Targeting GPC3

Phase 1/2 Withdrawn

Gastrointestinal

Simpson-Golabi-Behmel syndrome, Carcinoma, Hepatocellular